首页> Head & neck> Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins.

Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lauren,Hum

第一单位： Department of Oral and Maxillofacial Surgery, Oregon Health & Science University, Portland, Oregon, USA.

作者： Lauren,Hum ^[1] ; Daniel,Bethmann ^[2] ; Zipei,Feng ^[3] ; Shu-Ching,Chang ^[4] ; Alexander,Eckert ^[5] ; Carmen,Ballesteros-Merino ^[6] ; Claudia,Keschke ^[2] ; Matthias,Kappler ^[5] ; Carlo B,Bifulco ^[6] ; Claudia,Wickenhauser ^[2] ; Barbara,Seliger ^[7] ; Bernard A,Fox ^[8] ; Richard,Bryan Bell ^[9]

作者单位： Department of Oral and Maxillofacial Surgery, Oregon Health & Science University, Portland, Oregon, USA. ^[1] Institute of Pathology, University Hospital Halle, Halle, Germany. ^[2] Department of Otolaryngology, Baylor College of Medicine, Houston, Texas, USA. ^[3] Medical Data Research Center, Providence St. Joseph Health, Portland, Oregon, USA. ^[4] Department of Oral and Maxillofacial Plastic Surgery, University Hospital Halle, Halle, Germany. ^[5] Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, Oregon, USA. ^[6] Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. ^[7] Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, Oregon, USA.;Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA. ^[8] Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, Oregon, USA.;Providence Head and Neck Cancer Program and Clinic, Providence Cancer Institute, Portland, Oregon, USA. ^[9]

关键词 biomarker head and neck cancer immunotherapy margins oral cancer